title: Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants.
authors.affiliation: Department of Medicine II, University Hospital, Freiburg, Germany.
authors.forename: F
authors.initials: F
authors.lastname: von Weizsäcker
authors.forename: S
authors.initials: S
authors.lastname: Wieland
authors.forename: J
authors.initials: J
authors.lastname: Köck
authors.forename: W B
authors.initials: WB
authors.lastname: Offensperger
authors.forename: S
authors.initials: S
authors.lastname: Offensperger
authors.forename: D
authors.initials: D
authors.lastname: Moradpour
authors.forename: H E
authors.initials: HE
authors.lastname: Blum
mesh_terms: D015316:Genetic Therapy; D006525:Hepatitis, Viral, Human / Q000628:therapy*; D006801:Humans; D009154:Mutation; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D016337:RNA, Catalytic / Q000627:therapeutic use*; D014762:Viral Interference
chemical_list: D016376:Oligonucleotides, Antisense; D016337:RNA, Catalytic